InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the full record of transactions filed by Pottage John C Jr. Director active across 1 company, notably Spero Therapeutics, Inc.. Aggregated, 3 filings have been logged. History available since 15 September 2022. The latest transaction was disclosed on 29 May 2024 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
3 of 3 declarations